Moderna Inc. shares rose after the company posted a narrower third-quarter loss than Wall Street expected, a sign that its ...

Reports third quarter revenue of $1.0 billion, GAAP net loss of $(0.2) billion and GAAP EPS of $(0.51) Narrows 2025 projected ...

Heart rate. Blood pressure. Sleep measurements. Blood oxygen levels. Once upon a time, these measurements were usually only ...

PEMGARDA® (pemivibart) net product revenue of $13.1 million reported for Q3 2025, representing 41% growth year-over-year and 11% growth quarter-over-quarterOctober 2025 ending cash and cash ...

Johnson & Johnson said on Thursday it has asked U.S. health regulators to authorize its single-dose COVID-19 vaccine for ...

The top U.S. Food and Drug Administration official on Tuesday confirmed AstraZeneca Plc's U.S. COVID-19 vaccine trial is on ...

There's still a lot of confusion around the best time to take a COVID test and where to get them. Here, experts share their ...

Through his leadership at the FDA's Center for Biologics Evaluation and Research (CBER), Vinay Prasad, MD, MPH has pushed out at least 7 senior leaders and created an environment that employees worry ...

NV-387 Could be the Answer to the MPox Clade I Rising in the USA, Says Dr. Diwan ...

Get Q3 2025 Pfizer earnings call insights—guidance raised, major acquisitions, regulatory updates, and R&D highlights.

The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value ...